KRAS and non-small cell lung carcinoma: Thus, all further experiments were mainly performed with A549 and Pc-9 cells, widely used in biomedical studies and representing model cell lines for KRAS-mutation (A549) and EGFR-mutation (Pc-9), the two most frequently identified oncogenic drivers in NSCLC [20].